GeneOne Life Science, Inc. (KRX:011000)
South Korea flag South Korea · Delayed Price · Currency is KRW
848.00
-68.00 (-7.42%)
Last updated: Apr 29, 2026, 1:49 PM KST

GeneOne Life Science Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
77,072166,908168,840222,271553,6511,250,928
Upgrade
Market Cap Growth
-52.09%-1.14%-24.04%-59.85%-55.74%30.16%
Upgrade
Enterprise Value
108,295194,585188,532219,584509,9451,241,186
Upgrade
Last Close Price
850.001959.002115.002840.007140.0016200.00
Upgrade
PS Ratio
3.347.244.735.5311.3632.32
Upgrade
PB Ratio
1.884.081.971.993.056.06
Upgrade
P/TBV Ratio
1.894.101.982.003.066.08
Upgrade
EV/Sales Ratio
4.708.445.285.4610.4732.07
Upgrade
Debt / Equity Ratio
0.810.810.320.150.110.09
Upgrade
Net Debt / Equity Ratio
0.760.760.300.06-0.14-0.43
Upgrade
Net Debt / EBITDA Ratio
-1.21-1.21-1.01-0.200.753.89
Upgrade
Net Debt / FCF Ratio
-1.88-1.88-1.31-0.260.371.02
Upgrade
Asset Turnover
0.170.170.240.220.210.20
Upgrade
Inventory Turnover
2.562.562.973.233.103.17
Upgrade
Quick Ratio
0.070.070.240.771.663.36
Upgrade
Current Ratio
0.360.360.671.512.163.87
Upgrade
Return on Equity (ROE)
-81.98%-81.98%-49.25%-53.09%-19.67%-10.42%
Upgrade
Return on Assets (ROA)
-20.35%-20.35%-17.79%-16.17%-10.61%-8.88%
Upgrade
Return on Capital Employed (ROCE)
-67.30%-67.30%-39.50%-37.70%-21.30%-12.70%
Upgrade
Earnings Yield
-67.28%-31.07%-28.75%-34.99%-6.89%-1.27%
Upgrade
FCF Yield
-21.49%-9.93%-11.46%-12.30%-12.54%-6.98%
Upgrade
Buyback Yield / Dilution
-3.77%-3.77%-2.17%-0.34%-4.37%-22.98%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.